No Data
No Data
Guardant Health to Participate in Upcoming Investor Conferences
Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, today announced the company will participate in the following investor conferences. William Blair 44th Annual Growth Stock Conference in
Analysts Are Bullish on Top Healthcare Stocks: Guardant Health (GH), Durect (DRRX)
Analysts Offer Insights on Healthcare Companies: Inventiva (IVA), Lexaria Bioscience (LEXX) and Guardant Health (GH)
What's Going On With Colorectal Cancer Diagnostic-Focused Guardant Health Stock On Tuesday?
Tuesday, the FDA's staff reviewers raised concerns regarding Guardant Health Inc's (NASDAQ:GH) experimental blood test for colorectal cancer, suggesting it might not detect some tumor types that could
Express News | Guardant Health Shares Are Trading Lower After FDA Staff in a Briefing Said the Company's Test May Fail to Detect Some Types of Advanced Adenomas in Patients
Guardant Health Slips as FDA Comments on Cancer Screening Test
No Data